analyst
RL
NASDAQ · RLAY
Relay Therapeutics, Inc.
Healthcare · Biotechnology
$18.97
Down-$0.09 (-0.47%)
Updated Sep 16, 2026, 11:09 AM
SID Score
5.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.35B
- P/E ratio
- -4.52
- Dividend yield
- 0.00%
- 52-week range
- $9.27 – $21.27
- Volume
- 2.74M
- Avg. volume
- 1.93M
Price performance
RLAY price history
1M range · 20 trading sessions · Daily adjusted prices
RLAY closed at $18.97 after 20 trading sessions, down 7.96% for the selected period.
- Last close
- $18.97
- Period change
- -7.96%
- Period low
- $18.38
- Period high
- $20.74
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $19.05 | $19.09 | $18.64 | $18.97 | 2.74M |
| Sep 14, 2026 | $18.90 | $19.43 | $18.88 | $19.06 | 2.4M |
| Sep 11, 2026 | $19.17 | $19.35 | $18.675 | $18.87 | 4.16M |
| Sep 10, 2026 | $18.30 | $19.11 | $18.10 | $18.89 | 3M |
| Sep 9, 2026 | $18.76 | $19.185 | $18.54 | $18.66 | 6.06M |
| Sep 8, 2026 | $18.775 | $19.28 | $18.3141 | $19.11 | 5.03M |
| Sep 4, 2026 | $18.85 | $19.2569 | $18.68 | $19.04 | 2.05M |
| Sep 3, 2026 | $18.55 | $19.10 | $18.34 | $19.01 | 2.72M |
| Sep 2, 2026 | $18.70 | $19.27 | $18.29 | $18.51 | 2.11M |
| Sep 1, 2026 | $18.15 | $18.68 | $17.96 | $18.49 | 1.6M |
| Aug 31, 2026 | $18.54 | $18.64 | $18.03 | $18.38 | 3.78M |
| Aug 28, 2026 | $19.15 | $19.30 | $18.63 | $18.77 | 2.76M |
| Aug 27, 2026 | $19.23 | $19.68 | $19.16 | $19.42 | 2.39M |
| Aug 26, 2026 | $19.95 | $20.12 | $19.19 | $19.46 | 2.94M |
| Aug 25, 2026 | $20.175 | $20.77 | $20.05 | $20.57 | 2.74M |
| Aug 24, 2026 | $19.16 | $20.025 | $18.60 | $19.76 | 2.64M |
| Aug 21, 2026 | $19.92 | $20.17 | $19.18 | $19.44 | 2.97M |
| Aug 20, 2026 | $20.36 | $20.50 | $19.42 | $19.70 | 2.79M |
| Aug 19, 2026 | $21.05 | $21.27 | $20.45 | $20.74 | 2.1M |
| Aug 18, 2026 | $20.46 | $20.99 | $20.08 | $20.61 | 2.23M |
Latest RLAY news
The latest Smart Investors Daily articles mentioning RLAY.
Stock researchCompany · Forecast
Loading stock research…